BOTH GENETIC AND CLINICAL FACTORS PREDICT THE DEVELOPMENT OF GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
- 1 August 2001
- journal article
- immunobiology
- Published by Wolters Kluwer Health in Transplantation
- Vol. 72 (4) , 699-706
- https://doi.org/10.1097/00007890-200108270-00024
Abstract
Background. Graft-versus-host disease is the main complication of hematopoietic stem cell transplantation. Recently, pro- and anti-inflammatory cytokines and mismatches of minor histocompatibility antigens between HLA-identical sibling donor/recipient pairs have been implicated in the development of acute graft-versus-host disease. It is not known, however, whether these factors are independent of other clinically recognized risk factors such as age and disease stage. Methods. In this study, we searched for risk factors of acute graft-versus-host disease using multivariate Cox regression analysis in 100 consecutive patients who underwent allogeneic stem cell transplantation from an HLA-identical sibling donor. Eight polymorphisms from five different cytokine genes were studied (tumor necrosis factor α, tumor necrosis factor β, interleukin (IL) 6, IL-10, and interferon γ). Mismatches for the minor histocompatibility antigen HA-1 were searched in HLA-A*0201 individuals. In addition to these new risk factors, patient, donor, disease, and transplant risk factors were analyzed by multivariate analysis using the Cox proportional hazards model. Results. Acute graft-versus-host disease was independently associated with IL-10 gene polymorphisms both from the recipient (relative risk=7.9, P P =0.02), a donor’s positive serology for cytomegalovirus, and HA-1 mismatches in HLA-A*0201 individuals (relative risk=2.8, P =0.05). Chronic graft-versus-host disease was independently associated with IL-6 gene polymorphism from the recipient (relative risk=4.2, P =0.02), older age (relative risk=2.5, P =0.0009), and previous acute graft-versus-host disease (relative risk=9.7, P =0.003). Conclusion. In addition to previously described clinical risk factors, genetic risk factors are independently associated with the risk of developing graft-versus-host disease and may, thus, be considered for the selection of the donor.Keywords
This publication has 38 references indexed in Scilit:
- Unlinking Tumor Necrosis Factor Biology from the Major Histocompatibility Complex: Lessons from Human Genetics and Animal ModelsAmerican Journal of Human Genetics, 1999
- Definition of the gene encoding the minor histocompatibility antigen HA‐1 and typing for HA‐1 from genomic DNATissue Antigens, 1998
- Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical reportTransplant Immunology, 1998
- The Minor Histocompatibility Antigen HA-1: A Diallelic Gene with a Single Amino Acid PolymorphismScience, 1998
- Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)Bone Marrow Transplantation, 1997
- CYTOKINE CASCADES IN ACUTE GRAFT-VERSUS-HOST DISEASE1Transplantation, 1997
- Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapyImmunological Reviews, 1997
- Inflammatory reactions induced by pretransplant conditioning—An alternative target for modulation of acute GvHD and Complications following allogeneic bone marrow transplantation?Leukemia & Lymphoma, 1997
- Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)Blood, 1995
- Cytokine dysregulation and acute graft-versus-host diseaseBlood, 1992